PURCHASE AGREEMENTPurchase Agreement • January 14th, 2022 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • Illinois
THIS PURCHASE AGREEMENT (the "Agreement"), dated as of January 14, 2022, is made by and between X4 PHARMACEUTICALS, INC., a Delaware corporation (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the "Investor").
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 14th, 2022 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • Illinois
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January 14, 2022, is entered into by and between X4 PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
